Activating peroxisome proliferator-activated receptor gamma mutant promotes tumor growth in vivo by enhancing angiogenesis.

Cancer Research
Lifeng TianRichard G Pestell

Abstract

Peroxisome proliferator-activated receptor gamma (PPARgamma) is expressed in a variety of cancer cells. The addition of ligand activates the receptor by inducing a conformational change in the receptor, which can be recapitulated by mutation. To investigate the role of activated PPARgamma signaling in breast cancer, we compared the function of a constitutively active PPARgamma (PgammaCA) mutant with the wild-type PPARgamma in ErbB2-induced mammary tumorigenesis in vivo. Tumor cells transduced with either PPARgamma or PgammaCA were implanted into immunocompetent FVB mice. Enhanced tumor growth was observed in PgammaCA-transduced cells, which was associated with increased angiogenesis and endothelial stem cells as evidenced by increased number of cells stained with von Willebrand factor, c-Kit, CD133, and CD31. Genome-wide expression profiling identified a group of genes within the angiogenesis pathway, including Angptl4, as targets of activated PPARgamma; PgammaCA also induced Angptl4 protein secretion in ErbB2-transformed mammary epithelial cells. Angptl4 promoted vascular endothelial cell migration; conversely, immunodepletion of Angptl4 reduced PgammaCA-mediated cellular migration. Collectively, these studies suggest that act...Continue Reading

References

May 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·J B KimB M Spiegelman
Jul 14, 1998·Molecular Cell·E MuellerB M Spiegelman
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·G D DemetriS Singer
Jan 3, 2001·Nature Medicine·K J MooreM W Freeman
Jul 19, 2001·The Journal of Biological Chemistry·E D Rosen, B M Spiegelman
Sep 1, 2001·Trends in Molecular Medicine·M B SpornD J Mangelsdorf
Feb 9, 2002·European Journal of Pharmacology·Akihito AbeYukiko Tokumitsu
Apr 23, 2003·The American Journal of Pathology·Sébastien Le JanStéphane Germain
Jun 13, 2003·Molecular Biology of the Cell·Peter NeumeisterRichard G Pestell
Aug 15, 2003·Molecular and Cellular Biology·Chenguang WangRichard G Pestell
Oct 17, 2003·British Journal of Cancer·G DebrockA Van Oosterom
Feb 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Ebba BråkenhielmYihai Cao
Mar 24, 2004·Genes & Development·Enrique SaezRonald M Evans
May 5, 2005·Clinical Immunology : the Official Journal of the Clinical Immunology Society·L M HermannS Thornton
Jul 1, 2006·Molecular and Cellular Biology·Toshiyuki SakamakiRichard Pestell
Feb 27, 2007·Cardiovascular Research·Vishnu ChintalgattuLaxmansa C Katwa
Apr 27, 2007·Proceedings of the National Academy of Sciences of the United States of America·Xiaoming JuRichard G Pestell
Oct 10, 2007·Expert Opinion on Investigational Drugs·Costas GiaginisStamatios Theocharis
May 31, 2008·Circulation Research·Tongrong HeZvonimir S Katusic
Aug 30, 2008·American Journal of Physiology. Endocrinology and Metabolism·Olga GealekmanSilvia Corvera
Apr 8, 2009·The American Journal of Pathology·Manran LiuRichard G Pestell
Jul 1, 2009·The International Journal of Biochemistry & Cell Biology·Jie ZhouChenguang Wang

❮ Previous
Next ❯

Citations

Apr 3, 2013·European Journal of Pharmacology·Janine L BakkerHenk Verheul
Jun 19, 2013·Oncogene·X WangD S Conklin
Sep 15, 2012·Brain : a Journal of Neurology·Carmelo Lucio SturialeRoberto Pola
Feb 4, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Eunjung LeeAnna H Wu
Mar 26, 2010·World Journal of Biological Chemistry·Shou Wei Han, Jesse Roman
Jun 16, 2012·Cellular and Molecular Life Sciences : CMLS·Feng ZhangShizhong Zheng
Dec 22, 2015·Oncogene·K KramerD L Crowe
Apr 3, 2012·Expert Review of Proteomics·Charlotte GrootaertBarbara Vanhoecke
Mar 25, 2020·Current Opinion in Hematology·Carlos Fernández-Hernando, Yajaira Suárez
Apr 1, 2011·British Journal of Pharmacology·Jihan Youssef, Mostafa Badr
Jul 9, 2020·EMBO Molecular Medicine·Kyung Hee JungSoon-Sun Hong
May 2, 2017·Frontiers in Endocrinology·Helen J Knowles
Aug 14, 2020·International Journal of Molecular Sciences·Nicole Wagner, Kay-Dietrich Wagner
Aug 29, 2020·PPAR Research·Siyue DuKay-Dietrich Wagner
May 1, 2021·Biomedicines·Selin GencerEmiel P C van der Vorst
May 6, 2021·Cancers·Xuanmao JiaoRichard G Pestell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.